+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Artificial Tear"

Dry Eye Syndrome Market Report 2025 - Product Thumbnail Image

Dry Eye Syndrome Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Vernal Keratoconjunctivitis - Pipeline Insight, 2024 - Product Thumbnail Image

Vernal Keratoconjunctivitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Persistent Corneal Epithelial Defects (PCEDs) - Pipeline Insight, 2024 - Product Thumbnail Image

Persistent Corneal Epithelial Defects (PCEDs) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Allergic Conjunctivitis - Pipeline Insight, 2024 - Product Thumbnail Image

Allergic Conjunctivitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Neurotrophic Keratitis Market Outlook 2023-2036 - Product Thumbnail Image

Neurotrophic Keratitis Market Outlook 2023-2036

  • Report
  • January 2024
  • 155 Pages
  • Global
From
Loading Indicator

The Artificial Tear market within the Optical industry is a segment of the larger eye care market. It is composed of products designed to lubricate and moisturize the eyes, providing relief from dryness and irritation. Artificial tears are available in a variety of forms, including drops, gels, ointments, and sprays. They are typically used to treat dry eye syndrome, a condition caused by a lack of tear production. Artificial tears can also be used to treat other eye conditions, such as allergies, blepharitis, and contact lens discomfort. The Artificial Tear market is highly competitive, with a range of products available from both large and small companies. Some of the major players in the market include Allergan, Bausch + Lomb, Novartis, and Johnson & Johnson. Other companies include Alcon, Santen, and Ocular Science. Show Less Read more